As Talcum Powder Lawsuit Filings Grow In Number, Use Of Neoadjuvant Chemotherapy In Ovarian Cancer Treatment Increases

October 31, 2016 – – TheProductLawyers.com reports on a recent article by MedicalXpress concerning the use of certain chemotherapies in treating ovarian cancer.

According to the article, researchers from the University of Texas MD Anderson Cancer Center in Houston examined the use of NACT versus primary cytoreductive surgery (PCS) in a multi-center observational study.

“The researchers found that from 2003-2010 to 2011-2012 there was an increase in NACT use from 16 to 34 percent in stage IIIC disease and from 41 to 62 percent in stage IV disease. There was variation by institution in adoption of NACT, from 8 to 30 percent for stage IIIC disease and from 27 to 61 percent for stage IV disease,” the article said.

Studies on ovarian cancer have been highlighted in the news recently, given the thousands of lawsuits that have now been filed against companies such as Johnson & Johnson for their alleged knowledge of their products’ connection to ovarian cancer.

Johnson & Johnson’s Baby Powder became incredibly popular after 1892 when the director of scientific affairs Dr. Frederick B. Kilmer first invented a scented powder that was originally labeled “for toilet and nursery,” according to the Huffington Post. Many women then started using it to sprinkle it in their underwear and genital area for freshening purposes.

Thousands of women in the U.S. have now made similar claims alleging that Johnson & Johnson hid valuable medical information that prevented consumers from knowing the dangers of using the powders. Those plaintiffs further claim that the use of Johnson & Johnson’s powders as a feminine hygiene product are directly linked to ovarian cancer. Johnson & Johnson has denied claims that their products cause cancer and has stated that no causal link exists.

As these lawsuits are expected to grow in numbers, Banville Law is seeking to help those currently suffering. The firm has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed. Attorneys at Banville Law want to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.

For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60013023